Core Laboratories NV
NYSE:CLB

Watchlist Manager
Core Laboratories NV Logo
Core Laboratories NV
NYSE:CLB
Watchlist
Price: 21.12 USD 3.99% Market Closed
Market Cap: 991.6m USD
Have any thoughts about
Core Laboratories NV?
Write Note

Wall Street
Price Targets

CLB Price Targets Summary
Core Laboratories NV

Wall Street analysts forecast CLB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLB is 19.67 USD with a low forecast of 14.14 USD and a high forecast of 25.2 USD.

Lowest
Price Target
14.14 USD
33% Downside
Average
Price Target
19.67 USD
7% Downside
Highest
Price Target
25.2 USD
19% Upside

CLB Last Price Targets
Core Laboratories NV

The latest public price target was made on Jul 15, 2024 by Luke Lemoine from Piper Sandler , who expects CLB stock to drop by 20% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Luke Lemoine
Piper Sandler
17 USD
Downside 20%
4 months ago
Jul 15, 2024
Core Laboratories price target lowered to $17 from $18 at Piper Sandler
TheFly
Unknown Analyst
Citigroup
26 USD
Upside 23%
1 year ago
Feb 7, 2023
Citigroup Maintains Neutral on Core Laboratories, Raises Price Target to $26
Benzinga
Luke Lemoine
Piper Sandler
Price Target 17 USD
Upside/Downside 20%
View Source
Unknown Analyst
Citigroup
Price Target 26 USD
Upside/Downside 23%
View Source
Core Laboratories NV Competitors:
Price Targets
TCW
Trican Well Service Ltd
16% Upside
WFRD
Weatherford International PLC
62% Upside
HAL
Halliburton Co
24% Upside
CEU
CES Energy Solutions Corp
11% Upside
RNGR
Ranger Energy Services Inc
2% Downside
EFX
Enerflex Ltd
0% Upside
OII
Oceaneering International Inc
5% Downside
5WH
Rex International Holding Ltd
31% Downside

Revenue
Forecast

Revenue Estimate
Core Laboratories NV

For the last 8 years the compound annual growth rate for Core Laboratories NV's revenue is -5%. The projected CAGR for the next 3 years is 4%.

-5%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Core Laboratories NV

For the last 8 years the compound annual growth rate for Core Laboratories NV's operating income is -14%. The projected CAGR for the next 3 years is 15%.

-14%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Core Laboratories NV

For the last 8 years the compound annual growth rate for Core Laboratories NV's net income is -13%. The projected CAGR for the next 3 years is 12%.

-13%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-16%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLB's stock price target?
Price Target
19.67 USD

According to Wall Street analysts, the average 1-year price target for CLB is 19.67 USD with a low forecast of 14.14 USD and a high forecast of 25.2 USD.

What is Core Laboratories NV's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Core Laboratories NV's revenue is -5%. The projected CAGR for the next 3 years is 4%.

What is Core Laboratories NV's Operating Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Core Laboratories NV's operating income is -14%. The projected CAGR for the next 3 years is 15%.

What is Core Laboratories NV's Net Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Core Laboratories NV's net income is -13%. The projected CAGR for the next 3 years is 12%.

Back to Top